Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
D000818:Animals; D003342:Corpus Striatum / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology*; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology*; D007980:Levodopa / Q000009:adverse effects; D010300:Parkinson Disease / Q000503:physiopathology*; D011954:Receptors, Dopamine / Q000502:physiology; D013239:Stereotyped Behavior / Q000187:drug effects; D013569:Synapses / Q000502:physiology; D014149:Tranquilizing Agents / Q000009:adverse effects
D011954:Receptors, Dopamine; D014149:Tranquilizing Agents; D007980:Levodopa; D004298:Dopamine; D006719:Homovanillic Acid